Acarbose tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
From the U.S. FDA-approved label for Acarbose. Full label: DailyMed.
Acarbose tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
From the U.S. FDA-approved label for Acarbose. Full label: DailyMed.
There is no fixed dosage regimen for the management of diabetes mellitus with acarbose tablets or any other pharmacologic agent. Dosage of acarbose tablets must be individualized on the basis of both effectiveness and tolerance while not exceeding the maximum recommended dose of 100 mg t.i.d. Acarbose tablets should be taken three times daily at the start (with the first bite) of each main meal.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. Acarbose tablets are contraindicated in patients with diabetic ketoacidosis or cirrhosis. Acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
General Macrovascular Outcomes There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with acarbose tablets or any other anti-diabetic drug. Hypoglycemia Because of its mechanism of action, acarbose tablets when administered alone should not cause hypoglycemia in the fasted or postprandial state. Sulfonylurea agents or insulin may cause hypoglycemia. Because acarbose given in combination with a sulfonylurea or insulin will cause a further lowering of blood glucose, it may increase the potential for hypoglycemia.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
Digestive Tract Gastrointestinal symptoms are the most common reactions to acarbose tablets. In U.S. placebo-controlled trials, the incidences of abdominal pain, diarrhea, and flatulence were 19%, 31%, and 74% respectively in 1255 patients treated with acarbose tablets 50-300 mg t.i.d., whereas the corresponding incidences were 9%, 12%, and 29% in 999 placebo-treated patients.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
87 products from 51 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Acar 25 25mg Tablet | Acarbose (25mg) | National Healthcare Pvt. Ltd. | |
| Acar 50 50mg Tablet | Acarbose (50mg) | National Healthcare Pvt. Ltd. | |
| Acboz 25 25mg Tablet | Acarbose (25mg) | Time Pharmaceuticals Pvt. Ltd. | |
| Acboz 50 50mg Tablet | Acarbose (50mg) | Time Pharmaceuticals Pvt. Ltd. | |
| Arbo 25 25mg Tablet | Acarbose (25mg) | Nepal Pharmaceuticals Pvt. Ltd. | |
| Arbo 50 50mg Tablet | Acarbose (50mg) | Nepal Pharmaceuticals Pvt. Ltd. | |
| Diabay 25 25mg Tablet | Acarbose (25mg) | Omnica Laboratories Pvt. Ltd.. | |
| Diabay 50 50mg Tablet | Acarbose (50mg) | Omnica Laboratories Pvt. Ltd.. | |
| Diabose 25 mg Tablet | Acarbose (25 mg) | Micro Labs Ltd. | |
| Diabose 50 mg Tablet | Acarbose (50 mg) | Micro Labs Ltd. | |
| G Carb 25 25mg Tablet | Acarbose (25mg) | Vijayadeep Laboratories Pvt. Ltd. | |
| G Carb 50 50mg Tablet | Acarbose (50mg) | Vijayadeep Laboratories Pvt. Ltd. | |
| Glubose 25 25mg Tablet | Acarbose (25mg) | Aristo Pharmaceuticals Ltd. | |
| Glubose 50 50mg Tablet | Acarbose (50mg) | Aristo Pharmaceuticals Ltd. | |
| Glucar 25 mg Tablet | Acarbose (25 mg) | Glenmark Pharmaceuticals Ltd. | |
| Glucar 50 mg Tablet | Acarbose (50 mg) | Glenmark Pharmaceuticals Ltd. | |
| Glucobay 50 50mg Tablet | Acarbose (50mg) | Bayer Pharmaceuticals | |
| Glucor 25 25mg Tablet | Acarbose (25mg) | Glenmark Pharmaceuticals Ltd. | |
| Glucor 50 50mg Tablet | Acarbose (50mg) | Glenmark Pharmaceuticals Ltd. | |
| Abacus 50mg Tablet | Acarbose (50mg) | Nucron Pharmaceuticals Pvt Ltd | strip of 10 tablets |
| AC 25mg Tablet | Acarbose (25mg) | USV Ltd | strip of 10 tablets |
| AC 50mg Tablet | Acarbose (50mg) | USV Ltd | strip of 10 tablets |
| AC Bose 25 Tablet | Acarbose (25mg) | Capital Pharma | strip of 10 tablets |
| AC Bose 50mg Tablet | Acarbose (50mg) | Capital Pharma | strip of 10 tablets |
| AC Z Tablet | Acarbose (NA) | Acme Pharmaceutical | strip of 10 tablets |
| Acarb 25mg Tablet | Acarbose (25mg) | Mano Pharma Pvt Ltd | strip of 10 tablets |
| Acarb 50mg Tablet | Acarbose (50mg) | Mano Pharma Pvt Ltd | strip of 10 tablets |
| Acarbia 25mg Tablet | Acarbose (25mg) | Hauz Pharma Pvt Ltd | strip of 10 tablets |
| Acarbia 50mg Tablet | Acarbose (50mg) | Hauz Pharma Pvt Ltd | strip of 10 tablets |
| Acarboz 25mg Tablet | Acarbose (25mg) | Intas Pharmaceuticals Ltd | strip of 10 tablets |
Showing 30 of 87 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Protect from moisture. Keep container tightly closed.
Storage information from the U.S. FDA-approved label.
Acarbose is recorded in the NepalDoc medicine catalog for: Type 2 DM.
For Type 2 DM: Glibenclamide, Gliclazide, Glimepiride, Glipizide, Metformin, Repaglinide.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.